Pharmacokinetic-Pharmacodynamic Relationships of Immunoglobulin Therapy for Envenomation.
- Published in:
- Clinical Pharmacokinetics, 2003, v. 42, n. 8, p. 721
- By:
- Publication type:
- Article
Works matching IS 03125963 AND DT 2003 AND VI 42 AND IP 8
Results: 5
1
2
Platelet Glycoprotein IIb/IIIa Inhibitors in Percutaneous Coronary Intervention: Focus on the Pharmacokinetic-Pharmacodynamic Relationships of Eptifibatide.
- Published in:
- Clinical Pharmacokinetics, 2003, v. 42, n. 8, p. 703, doi. 10.2165/00003088-200342080-00001
- By:
- Publication type:
- Article
3
Ximelagatran, an oral direct thrombin inhibitor, has a low potential for cytochrome P450-mediated drug-drug interactions.
- Published in:
- 2003
- By:
- Publication type:
- journal article
4
No influence of mild-to-moderate hepatic impairment on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
- Published in:
- 2003
- By:
- Publication type:
- journal article
5
Influence of severe renal impairment on the pharmacokinetics and pharmacodynamics of oral ximelagatran and subcutaneous melagatran.
- Published in:
- 2003
- By:
- Publication type:
- journal article